期刊
FUTURE VIROLOGY
卷 12, 期 4, 页码 193-213出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fvl-2016-0129
关键词
cancer therapy; oncolytic immunotherapy; oncolytic virotherapy; virus engineering; virus targeting
类别
资金
- NIH [CA186781-02A1P1]
Oncolytic viruses (OVs) are engineered and/or evolved to propagate selectively in cancerous tissues. They have a dual mechanism of action; direct killing of infected cancer cells cross-primes anticancer immunity to boost the killing of uninfected cancer cells. The goal of the field is to develop OVs that are easily manufactured, efficiently delivered to disseminated sites of cancer growth, undergo rapid intratumoral spread, selectively kill tumor cells, cause no collateral damage and pose no risk of transmission in the population. Here we discuss the many virus engineering strategies that are being pursued to optimize delivery, intratumoral spread and safety of OVs derived from different virus families. With continued progress, OVs have the potential to transform the paradigm of cancer care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据